Your browser doesn't support javascript.
loading
mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein.
Guglielmelli, Tommasina; Giugliano, Emilia; Brunetto, Vanessa; Rapa, Ida; Cappia, Susanna; Giorcelli, Jessica; Rrodhe, Sokol; Papotti, Mauro; Saglio, Giuseppe.
Afiliação
  • Guglielmelli T; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Giugliano E; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Brunetto V; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Rapa I; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Cappia S; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Giorcelli J; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Rrodhe S; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Papotti M; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
  • Saglio G; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Oncoscience ; 2(4): 382-94, 2015.
Article em En | MEDLINE | ID: mdl-26097872

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoscience Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoscience Ano de publicação: 2015 Tipo de documento: Article